In our 3 episode of The AI Leader, we are joined by Talking Medicine's Chief Operating & Data Officer, Elizabeth Fairley. We discuss their data science evolution, data protection and security within the healthcare sector, their use of Gen AI partularly within their core product, DrugGPT, what it's like to grow an international business headquartered in Scotlnd and how AI will continue to disrupt the healthcare and pharma markets.

Elizabeth's Bio:

Elizabeth Fairley is a passionate co-founder of Talking Medicines, driving the development and commercialization of the data intelligence platform, Drug-GPT. Her expertise lies in leveraging data to empower agencies in the pharmaceutical sector with actionable insights. Elizabeth is dedicated to transforming patient outcomes through data-based predictive health, decoding patient/HCP/KOL/DOL language to uncover meaningful experiences. As a leading industry voice, she shares her knowledge on data mining, ethical data use, and the value of conversational data in understanding the patient experience. Elizabeth has completed an accelerated MBA at Babson (Saltire Fellow, Boston, US), holds a Ph.D. in Biology from the University of Cambridge, and a BSc (Hons) in Genetics from the University of Aberdeen. She is committed to diversity and fostering young talent, with a focus on innovation, trust, and transparency. As an entrepreneur, Elizabeth has founded various successful enterprises, including her own life sciences consultancy business.

Hosted on Acast. See acast.com/privacy for more information.